Mechanosensitive pore opening of a prokaryotic voltage-gated sodium channel

  1. Peter R Strege
  2. Luke M Cowan
  3. Constanza Alcaino
  4. Amelia Mazzone
  5. Christopher A Ahern
  6. Lorin S Milescu  Is a corresponding author
  7. Gianrico Farrugia  Is a corresponding author
  8. Arthur Beyder  Is a corresponding author
  1. Mayo Clinic, United States
  2. University of Iowa, United States
  3. University of Maryland, College Park, United States

Abstract

Voltage-gated ion channels orchestrate electrical activities that drive mechanical functions in contractile tissues such as the heart and gut. In turn, contractions change membrane tension and impact ion channels. Voltage-gated ion channels are mechanosensitive, but the mechanisms of mechanosensitivity remain poorly understood. Here, we leverage the relative simplicity of NaChBac, a prokaryotic voltage-gated sodium channel from Bacillus halodurans, to investigate mechanosensitivity. In whole-cell experiments on heterologously transfected HEK293 cells, shear stress reversibly altered the kinetic properties of NaChBac and increased its maximum current, comparably to the mechanosensitive eukaryotic sodium channel NaV1.5. In single-channel experiments, patch suction reversibly increased the open probability of a NaChBac mutant with inactivation removed. A simple kinetic mechanism featuring a mechanosensitive pore opening transition explained the overall response to force, whereas an alternative model with mechanosensitive voltage sensor activation diverged from the data. Structural analysis of NaChBac identified a large displacement of the hinged intracellular gate, and mutagenesis near the hinge diminished NaChBac mechanosensitivity, further supporting the proposed mechanism. Our results suggest that NaChBac is overall mechanosensitive due to the mechanosensitivity of a voltage-insensitive gating step associated with the pore opening. This mechanism may apply to eukaryotic voltage-gated ion channels, including NaV1.5.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file; Source Data files have been provided for Figures 1 - 5 and Supplements to Figures 1 - 3, and 5.

Article and author information

Author details

  1. Peter R Strege

    Department of Medicine, Mayo Clinic, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Luke M Cowan

    Department of Medicine, Mayo Clinic, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5512-1227
  3. Constanza Alcaino

    Department of Medicine, Mayo Clinic, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Amelia Mazzone

    Department of Medicine, Mayo Clinic, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Christopher A Ahern

    Department of Molecular Physiology and Biophysics, University of Iowa, Iowa City, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7975-2744
  6. Lorin S Milescu

    Department of Biology, University of Maryland, College Park, College Park, United States
    For correspondence
    lorinsmilescu@gmail.com
    Competing interests
    The authors declare that no competing interests exist.
  7. Gianrico Farrugia

    Department of Medicine, Mayo Clinic, Rochester, United States
    For correspondence
    farrugia.gianrico@mayo.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3473-5235
  8. Arthur Beyder

    Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, United States
    For correspondence
    Beyder.Arthur@mayo.edu
    Competing interests
    The authors declare that no competing interests exist.

Funding

NIDDK (DK052766)

  • Gianrico Farrugia
  • Arthur Beyder

NIDDK (DK123549)

  • Arthur Beyder

NIH (AT010875)

  • Arthur Beyder

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2023, Strege et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,444
    views
  • 254
    downloads
  • 7
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Peter R Strege
  2. Luke M Cowan
  3. Constanza Alcaino
  4. Amelia Mazzone
  5. Christopher A Ahern
  6. Lorin S Milescu
  7. Gianrico Farrugia
  8. Arthur Beyder
(2023)
Mechanosensitive pore opening of a prokaryotic voltage-gated sodium channel
eLife 12:e79271.
https://doi.org/10.7554/eLife.79271

Share this article

https://doi.org/10.7554/eLife.79271

Further reading

    1. Cell Biology
    Kaili Du, Hongyu Chen ... Dan Li
    Research Article

    Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.

    1. Cell Biology
    2. Developmental Biology
    Sarah Y Coomson, Salil A Lachke
    Insight

    A study in mice reveals key interactions between proteins involved in fibroblast growth factor signaling and how they contribute to distinct stages of eye lens development.